The 20 Best Penile Cancer Doctors Near Me in Ann Arbor, MI

Dr. Jeffery Montgomery's clinical interests include the diagnosis and management of bladder, prostate, and penile and testicular cancers. With his advanced training in urologic oncology and minimally invasive surgical techniques, such as robotic, laparoscopic and complex open surgery, he is able to deliver state-of-the-art care to his patients. He has expertise in state-of-the-art diagnostics for prostate cancer, including prostate MRI, fusion prostate biopsy, and transperineal standard and fusion prostate biopsies. He has extensive experience performing advanced robotic surgery, including prostatectomy, cystectomy with intra-corporeal urinary diversions, and inguinal lymph node dissections. Dr. Montgomery's research focuses on improving the quality and efficiency of urologic oncology disease management. Dr. Montgomery is a Michigan native and earned his undergraduate degree from the University of Michigan. He then went on to complete his medical education at the Columbia University College of Physicians and Surgeons in New York before finishing his Urology residency at the University of Michigan. He completed his urologic oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Montgomery is rated as an Elite provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Montgomery is board certified in Urology.

Todd M. Morgan, M.D. is a urological surgeon specializing in the treatment of genitourinary malignancies. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology at Vanderbilt University. Dr. Morgan is a translational surgeon-scientist, and his research spans the spectrum from preclinical laboratory-based research to prospective clinical trials. The primary focus of his laboratory is on identifying key pathways that predict response and resistance to treatment in genitourinary malignancies. This includes work in prostate cancer to develop liquid biopsy approaches that can guide precision-based therapeutic strategies in real time, as well as ongoing research in renal cell carcinoma to identify genomic signatures for risk stratification.Dr. Morgan is currently an Associate Professor of Urology and has been at the University of Michigan since 2012. In addition to his research pursuits, he is a busy clinician and surgeon offering advanced robotic, laparoscopic, and open surgical approaches for patients with genitourinary malignancies. He has substantial expertise in the use and interpretation of molecular biomarkers, which can help guide individualized treatment choice for some patients.Beyond work, he loves his time enjoying the great town of Ann Arbor and beautiful state of Michigan with his wife, Wendy, and their two young boys. Whether camping in Petoskey, sitting on a beach in Grand Haven, or biking around the neighborhood in Ann Arbor, the Morgan family has quickly learned that life in the Midwest is hard to beat. Dr. Morgan is rated as a Distinguished provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Morgan is board certified in Urology.

Nikita Consul is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Consul is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. Her clinical expertise encompasses Giant Mammary Hamartoma, Liver Cancer, Bannayan-Riley-Ruvalcaba Syndrome, and Lhermitte-Duclos Disease. Dr. Consul is board certified in Diagnostic Radiology.

John Stoffel is a General Surgeon and a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Stoffel is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Neurogenic Bladder, Urinary Incontinence, Urinary Tract Infection (UTI), Reconstructive Urology Surgery, and Hernia Surgery. Dr. Stoffel is board certified in Urology and Female Pelvic Medicine & Reconstructive Surg.

Ajjai Alva is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Alva is rated as an Advanced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Lymphadenectomy.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as an Advanced provider by MediFind in the treatment of Penile Cancer. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as an Advanced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Advanced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Yooni Blair is deeply committed to improving the lives of her patients through innovative urological care. She completed her Urology residency at the University of Michigan, where she developed a passion for genitourinary reconstruction. To further her expertise, she pursued a fellowship in Genitourinary Reconstruction, Prosthetics, and Trauma at the University of Texas Southwestern Medical Center, gaining extensive experience in treating conditions such as narrowed urethras, erectile dysfunction, and urinary incontinence. With numerous publications and presentations at national conferences, Dr. Blair stays at the forefront of her field, always striving to enhance her patients' quality of life. Many of her patients have experienced marked improvements in their symptoms, such as increased urinary flow and regaining erectile function, following her tailored treatment plans, which underscores her commitment to delivering effective, individualized care. Active in professional organizations, including the Society of Genitourinary Reconstructive Surgery, Dr. Blair also serves on the American Urologic Association Video Education Committee and the Sexual Medicine Society of North America Surgical Committee, emphasizing her dedication to advancing the field. In addition, her passion for global medicine has taken her to Peru, Ecuador, the Dominican Republic, Ghana, Honduras, and Rwanda. She has worked to address health disparities by participating in the training of local physicians to improve access to underserved populations. In her role as Associate Residency Program Director, she focuses on educating future urologists and promoting leadership development. Dr. Blair looks forward to partnering with her patients on their journey to health and well-being. Dr. Blair is rated as an Advanced provider by MediFind in the treatment of Penile Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Urethral Stricture, Peyronie Disease, Priapism, Bladder Outlet Obstruction, and Ureteroscopy.

Dr. Jackson is an Assistant Professor in the Department of Radiation Oncology at the University of Michigan. He performed his residency in radiation oncology at the University of Michigan, and subsequently joined the faculty upon completion of his training. Within the Department of Radiation Oncology, he serves as the co-Chief of the Genitourinary Radiotherapy Program. Within the Rogel Cancer he is the co-Director of the multidisciplinary Spine Oncology Program.Dr. Jackson’s research focuses mainly on improving outcomes for men with aggressive or recurrent prostate cancer, and he has published extensively on this topic. Dr. Jackson is rated as an Advanced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Penile Cancer. Dr. Jackson is board certified in Radiation Oncology.

Zachery Reichert is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Reichert is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Bladder Cancer, and Prostatectomy.

Dr. David Smith is a Professor of Internal Medicine and Urology at the University of Michigan and currently serves as the Associate Chief Clinical Officer for Cancer at Michigan Medicine and the Chief Medical Officer of the Rogel Cancer Center. Throughout his career he has focused on caring for patients with urologic cancers, cancer clinical trials, and the delivery of cancer care. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Orchiectomy, and Prostatectomy.

Lindsey Herrel is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Herrel is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Vasectomy, and Nephrectomy. Dr. Herrel is board certified in Urology.

Bahaa Malaeb, MD, FACS, joined the University of Michigan, Department of Urology in August 2012 after completing a fellowship in Genitourinary Trauma and Reconstructive Urology at the University of Washington, Seattle. Prior to that, he finished his residency in urology (2011) and a research fellowship in urologic oncology (2006) at the University of Minnesota, Minneapolis. Born and raised in Beirut, Lebanon, Dr. Malaeb completed his undergrad at the American University of Beirut (1999) and obtained his MD from the same institution (2003).Dr. Malaeb's clinical focus and practice include evaluating and managing genitourinary trauma in the immediate and the delayed setting. His reconstructive practice spans both upper and lower urinary tracts. The typical surgeries he performs include urethroplasties for stricture disease, penile reconstruction, prosthetic surgery for Peyronie's disease, erectile dysfunction, and surgeries for management of male incontinence. He manages urologic trauma in the acute setting as well as delayed presentation. Dr. Malaeb also is involved in the gender program and collaborates with plastic surgery and GYN in gender reassignment procedures. His research interests mirror his clinical practice and involve urinary incontinence in men, trends and outcomes, urologic prosthetics, and urethral stricture disease.Dr. Malaeb is very excited to be part of the University of Michigan, Department of Urology, as he gets the opportunity to work at one of the nation's leading programs. The opportunities for research and collaboration are unmatched, and the patient population is diverse and challenging. He enjoys working with the residents and is committed to teaching in a clinic and operating room setting. On a personal level, he is getting to enjoy the fantastic setting of a beautiful college town with easy access to a vast range of activities, from fine dining and a great art scene to fun outdoor activities. Dr. Malaeb is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Urethral Stricture, Peyronie Disease, Bladder Outlet Obstruction, Reconstructive Urology Surgery, and Ureteroscopy. Dr. Malaeb is board certified in Urology.

Simpa S. Salami, M.D., M.P.H. is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his medical degree from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he completed a Master of Public Health program at Harvard University, General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami’s clinical expertise is in the minimally invasive surgical treatment of prostate and kidney cancer. As a translational surgeon-scientist, his laboratory focuses on developing novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response. Dr. Salami’s lab collaborates with investigators all over the world to understand the molecular underpinnings of urologic cancer and associated disparities. Dr. Salami is a recipient of several awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, Society of Urologic Oncology Young Investigator, NCI R37 MERIT and 2024 AUA Gold Cystoscope Awards. Most recently, he was named an inaugural Biden White House Cancer Moonshot Scholar. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation. Dr. Salami is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Salami is board certified in Urology.

Khaled Hafez is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Hafez is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Hafez is board certified in Urology.

Dr. Palmbos received his bachelor’s degree from Calvin College in Grand Rapids, Michigan where he graduated with honors in 2000. He completed his combined M.D. and Ph.D. degrees as part of a NIH sponsored medical scientist training program at the University of Michigan Medical School in Ann Arbor, Michigan in 2008. His graduate work focused on the nonhomologous endjoining pathway of DNA double strand break repair. He then completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan in 2010 and 2014 respectively. His clinical interest is genitourinary malignancies and he primarily sees patients with bladder and prostate cancers. His laboratory research focus is on bladder cancer and he is currently developing new preclinical models of bladder cancer and focusing on the role of a novel oncogene, ATDC, in bladder tumor development. He recently received American Society of Clinical Oncology (ASCO) Young Investigator and Bladder Cancer Advocacy Network (BCAN) Young Investigator awards and has an NIH K08 award to develop his research program. Dr. Palmbos is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, and Urothelial Cancer. Dr. Palmbos is board certified in Internal Medicine and Medical Oncology.

Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Ganglioneuroblastoma, Rhabdomyosarcoma, Rhabdoid Tumor Predisposition Syndrome, and Rhabdoid Tumor.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Dr. Dess is an Associate Professor in the Department of Radiation Oncology at the University of Michigan.He attended medical school at University of Chicago and completed his residency in radiation oncology at the University of Michigan.He practices in several locations. At the University of Michigan Ann Arbor main campus, he is the co-Chief of Genitourinary Radiotherapy Service, and also leads the high dose rate (HDR) prostate brachytherapy program. At the Brighton Center for Specialty Care, he serves as the primary genitourinary radiation oncologist.Dr. Dess is a clinical and translational researcher focused on genitourinary malignancy. He has worked with a global network of collaborators to create novel prognostic models to characterize prostate cancer disease aggressiveness, to identify novel prognostic and predictive biomarkers, to analyze racial outcomes differences and settings in which disparities are minimized, and to advance more convenient forms of treatment including stereotactic body radiation therapy (SBRT) and high-dose rate brachytherapy (HDR). He is interested in maximizing efficacy, minimizing burden, and understanding the long-term toxicity risks of treatment. His work has been published high profile in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, and JAMA Oncology.Dr. Dess also serves as the co-lead for prostate cancer within the Michigan Radiation Oncology Quality Consortium (MROQC) where he works to improve state-wide care. Dr. Dess is rated as an Experienced provider by MediFind in the treatment of Penile Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Dess is board certified in Radiation Oncology.